Komori
Kidswell Bio (4584) · InitiativeAdvanced

Strengthening the Financial Position and Improving Asset Efficiency through the Sale of Investment Securities

First written in FY2022-Q2. 2 of 4 entries say "Advanced", first in FY2025. Latest entry: 2026-09-18.

4entries
6years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2022-Q3 – 2026-09-182021: 12022: 120222023: 020232024: 020242025: 120252026: 12026
Same theme, other companies
Improving asset efficiency and financial strength through the sale of investment securitiesA theme 30 companies write about · 0 as a headwind · 30 as a tailwind

17 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 30 companies compared. The sentences above are computed from all 30.
Full recordFilings, disclosures and news, newest first
  1. 2026-09-18AdvancedOccurring Fact

    「財務体質の強化及び資産効率の向上のため、当社保有の投資有価証券の一部を売却、当該売却益を計上する見込みであります。」

    投資有価証券の売却について、2026年9月1日から18日に上場有価証券1銘柄を売却し、売却益221,717千円を計上する見込みと開示した。
  2. FY2025AdvancedAnnual report

    「Funds generated by investing activities totaled ¥65.077 million. This was mainly attributable to proceeds of ¥88.948 million from the sale of investment securities.」

    To improve its financial position and asset efficiency, the Company sold investment securities for ¥88.948 million and recognized a gain on sale of ¥66.330 million.
  3. FY2022-Q3AchievedAnnual report

    「In addition, on 21 October 2021, the Company sold 1 listed security that it held and has continued efforts to strengthen its financial position and improve asset efficiency.」

    The Company sold 1 listed security on 21 October 2021 to strengthen its financial position and improve asset efficiency.
  4. FY2022-Q2First statedAnnual report

    「Reason for sale of investment securities To strengthen the financial position and improve asset efficiency Shares sold: 1 listed security held by the Company Gain on sale of investment securities: ¥417.736 million」

    The Company newly indicated that it planned to sell 1 listed security it held on 21 October 2021 to strengthen its financial position and improve asset efficiency, recognizing a gain on sale of ¥417.736 million.
Moved together

"Enhancing Development Capabilities and Speed Through Partnerships with Contract Research Organizations and Pharmaceutical Companies" moved the same way as this thread, in the same document, in 2 of its 4 moves.

22★12
  1. ★This thread
  2. 1Enhancing Development Capabilities and Speed Through Partnerships with Contract Research Organizations and Pharmaceutical Companies2×
  3. 2Generating Contract Payments, Milestones and Service Revenue from the R&D Stage2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Kidswell Bio yet. It last moved in the Occurring Fact of 2026-09-18: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Strengthening the Financial Position and Improving Asset Efficiency through the Sale of Investment Securities | Kidswell Bio Corporation (4584) | Komori